Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed at $7.9 up 0.89% from its previous closing price of $7.83. In other words, the price has increased by $0.89 from its previous closing price. On the day, 0.59 million shares were traded. PHAT stock price reached its highest trading level at $7.9 during the session, while it also had its lowest trading level at $7.61.
Ratios:
For a deeper understanding of Phathom Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 3.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 16 ’25 when Breedlove Robert Charles sold 1,692 shares for $8.36 per share. The transaction valued at 14,152 led to the insider holds 48,392 shares of the business.
Topper James N bought 3,780 shares of PHAT for $14,609 on May 21 ’25. The Director now owns 59,403 shares after completing the transaction at $3.86 per share. On May 14 ’25, another insider, Topper James N, who serves as the Director of the company, bought 6,300 shares for $3.32 each. As a result, the insider paid 20,919 and bolstered with 55,623 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 551531392 and an Enterprise Value of 898965440. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.74. Its current Enterprise Value per Revenue stands at 10.982 whereas that against EBITDA is -3.147.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.45, which has changed by -0.3106457 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $2.21. The 50-Day Moving Average of the stock is 8.46%, while the 200-Day Moving Average is calculated to be -2.07%.
Shares Statistics:
For the past three months, PHAT has traded an average of 2.74M shares per day and 857790 over the past ten days. A total of 69.64M shares are outstanding, with a floating share count of 37.85M. Insiders hold about 45.79% of the company’s shares, while institutions hold 47.33% stake in the company. Shares short for PHAT as of 1751241600 were 8520349 with a Short Ratio of 3.11, compared to 1748563200 on 10981222. Therefore, it implies a Short% of Shares Outstanding of 8520349 and a Short% of Float of 20.369999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
